29 Antibacterial effects of the MEK1/2 inhibitor ATR-002 on Staphylococcus aureus

Objectives/Goals: Pulmonary infections by Staphylococcus aureus (S. aureus) are difficult to eradicate in people with cystic fibrosis (CF, PwCF) and remain a significant disease burden. Our objective is to determine if a MEK1/2 inhibitor, ATR-002, can reduce S. aureus biofilm growth and synergize wi...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Eryn Zuiker, Gregory Serpa, Yiwei Liu, Daniel J. Wozniak, Kymberly M. Gowdy, Susan E. Birket, Megan R. Kiedrowski, Emily A. Hemann, Matthew E. Long
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Cambridge University Press 2026-04-01
coleção:	Journal of Clinical and Translational Science
Acesso em linha:	https://www.cambridge.org/core/product/identifier/S2059866126102623/type/journal_article
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!